Translating evidence of HDL and plaque regression

Belinda A. Di Bartolo, Peter J. Psaltis, Christina A. Bursill, Stephen J. Nicholls

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Considerable evidence from preclinical and population studies suggests that HDLs (high-density lipoproteins) possess atheroprotective properties. Reports from HDL infusion studies in animals and early clinical imaging trials reported evidence of plaque regression. These findings have stimulated further interest in developing new agents targeting HDL. However, the results of more recent imaging studies in the setting of high-intensity statin use have been disappointing. As the concept of plaque changes with HDL therapeutics evolves and imaging technology to evaluate these effects advances, there will become increasing opportunity to determine the effects of HDL agents on atherosclerotic plaque (Graphic Abstract). Visual Overview-An online visual overview is available for this article.

LanguageEnglish
Pages1961-1968
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume38
Issue number9
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Animals
  • Atherosclerosis
  • Lipids
  • Research
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{a70a9ae9a1c24594b825a946586cebab,
title = "Translating evidence of HDL and plaque regression",
abstract = "Considerable evidence from preclinical and population studies suggests that HDLs (high-density lipoproteins) possess atheroprotective properties. Reports from HDL infusion studies in animals and early clinical imaging trials reported evidence of plaque regression. These findings have stimulated further interest in developing new agents targeting HDL. However, the results of more recent imaging studies in the setting of high-intensity statin use have been disappointing. As the concept of plaque changes with HDL therapeutics evolves and imaging technology to evaluate these effects advances, there will become increasing opportunity to determine the effects of HDL agents on atherosclerotic plaque (Graphic Abstract). Visual Overview-An online visual overview is available for this article.",
keywords = "Animals, Atherosclerosis, Lipids, Research, Risk factors",
author = "{Di Bartolo}, {Belinda A.} and Psaltis, {Peter J.} and Bursill, {Christina A.} and Nicholls, {Stephen J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1161/ATVBAHA.118.307026",
language = "English",
volume = "38",
pages = "1961--1968",
journal = "Arteriosclerosis, thrombosis, and vascular biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

Translating evidence of HDL and plaque regression. / Di Bartolo, Belinda A.; Psaltis, Peter J.; Bursill, Christina A.; Nicholls, Stephen J.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38, No. 9, 01.01.2018, p. 1961-1968.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Translating evidence of HDL and plaque regression

AU - Di Bartolo, Belinda A.

AU - Psaltis, Peter J.

AU - Bursill, Christina A.

AU - Nicholls, Stephen J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Considerable evidence from preclinical and population studies suggests that HDLs (high-density lipoproteins) possess atheroprotective properties. Reports from HDL infusion studies in animals and early clinical imaging trials reported evidence of plaque regression. These findings have stimulated further interest in developing new agents targeting HDL. However, the results of more recent imaging studies in the setting of high-intensity statin use have been disappointing. As the concept of plaque changes with HDL therapeutics evolves and imaging technology to evaluate these effects advances, there will become increasing opportunity to determine the effects of HDL agents on atherosclerotic plaque (Graphic Abstract). Visual Overview-An online visual overview is available for this article.

AB - Considerable evidence from preclinical and population studies suggests that HDLs (high-density lipoproteins) possess atheroprotective properties. Reports from HDL infusion studies in animals and early clinical imaging trials reported evidence of plaque regression. These findings have stimulated further interest in developing new agents targeting HDL. However, the results of more recent imaging studies in the setting of high-intensity statin use have been disappointing. As the concept of plaque changes with HDL therapeutics evolves and imaging technology to evaluate these effects advances, there will become increasing opportunity to determine the effects of HDL agents on atherosclerotic plaque (Graphic Abstract). Visual Overview-An online visual overview is available for this article.

KW - Animals

KW - Atherosclerosis

KW - Lipids

KW - Research

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85055611350&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.118.307026

DO - 10.1161/ATVBAHA.118.307026

M3 - Article

VL - 38

SP - 1961

EP - 1968

JO - Arteriosclerosis, thrombosis, and vascular biology

T2 - Arteriosclerosis, thrombosis, and vascular biology

JF - Arteriosclerosis, thrombosis, and vascular biology

SN - 1079-5642

IS - 9

ER -